Domain Associates, LLC

Portfolio Companies (Active)

		Achaogen, Inc. Pursuing unique strategies to prevent drug resistance

		Achillion Pharmaceuticals, Inc. Dedicated to bringing important new treatments to patients wih infectious disease

		Afferent Pharmaceuticals, Inc. Focused on developing first-in-class medicines to treat pain

		Alimera Sciences, Inc. Development and marketing of in-licensed ophthalmology products

		Altair Therapeutics, Inc. Developing novel therapeutics to treat human respiratory diseases

		Altea Therapeutics Corporation Delivery of drugs across the skin

		Apnex Medical, Inc. Developing a device-based treatment for obstructive sleep apnea

		Ascenta Therapeutics, Inc. Anti-cancer drug development

		Asmacure, Inc. Developing therapeutics for the treatment of asthma

		Astute Medical, Inc. Developing innovative, high value, biomarker solutions for the acute hospital setting

		BioVascular, Inc. Developing solutions for reducing inflammation and thrombosis

		Cadence Pharmaceuticals, Inc. Development and marketing of acute care drugs with an initial focus on anti-infectives

		Carticept Medical, Inc. Development and sales of therapeutically related medical devices

		Celator Pharmaceuticals, Inc. Development of proprietary fixed dose combinations of chemotherapeutic agents for cancer treatment

		Cell Biosciences, Inc. Lab instrumentation enabling analysis of cell signaling activity

		Clovis Oncology, Inc. Focused on acquiring, developing and commercializing innovative anti-cancer agents

		CoDa Therapeutics, Inc. Development and commercialization of wound care therapeutics based on gap junction modulation

		CoLucid Pharmaceuticals, Inc. Developing innovative therapies to treat CNS disorders

		Corridor Pharmaceuticals, Inc. Developing therapeutics for vascular and pulmonary indications
Corridor Pharmaceuticals, Inc.

		Dicerna Pharmaceuticals, Inc. Developing RNA dicer substrates to treat a variety of diseases

		Durata Therapeutics, Inc. Development of Dalbavancin, a glycopeptide anti-bacterial agent
Durata Therapeutics, Inc.

		Eddingpharm (Cayman) Inc. Marketing oncology products in China

		Esperion Therapeutics, Inc. Developing pharmaceutical products for the treatment of cardiovascular and metabolic diseases

		Evoke Pharma, Inc. Acquisition and development of proprietary products for the treatment of gastrointestinal diseases

		Five Prime Therapeutics, Inc. Expression and screening of all secreted proteins to find relevant protein therapeutics

		Foundry Newco XII, Inc. An incubator focused on developing the next generation of medical device innovations
Foundry Newco XII, Inc.

		GenVault Corporation High capacity DNA storage systems

		GI Dynamics, Inc. Device to treat obesity

		Glaukos Corporation Device to treat glaucoma

		Goodwell Technologies, Inc. IT to allow for remote doctor-patient interaction

		IntegenX Inc. Developing equipment for molecular diagnostics

		Lithera, Inc. Developing products for aesthetic medicine to address both medical and lifestyle indications

		Marinus Pharmaceuticals, Inc. Development of therapeutics for treatment of CNS disorders and pain

		Meritage Pharma, Inc. Developing drugs for gastrointestinal diseases

		Miramar Labs, Inc. Developing devices for aesthetic indications

		Neuralieve, Inc. Developing a non-invasive medical device to treat migraine headaches

		Neuron Systems, Inc. Developing novel therapeutics for the treatment of eye diseases

		NeuroPace, Inc. Device to treat epilepsy

		Novadigm Therapeutics, Inc. Developing vaccines and therapeutics to prevent and treat infectious diseases

		Novalar Pharmaceuticals, Inc. Development of dental medications

		Nuon Therapeutics, Inc. Developing medicines to treat autoimmune disease

		Ocera Therapeutics, Inc. Development of drugs to treat gastrointestinal diseases

		Optherion, Inc. Developing therapeutics for diseases involving the complement system, with an initial focus on AMD

		Oraya Therapeutics, Inc. Developing a radiation-based treatment for wet AMD

		Orexigen Therapeutics, Inc. Anti-obesity drug development

		Otonomy, Inc. Developing novel drug therapies for disorders of the inner and middle ear

		ParinGenix, Inc. Developing a proprietary, modified form of heparin to treat a range of inflammatory diseases

		Regado Biosciences, Inc. Developing rapidly reversible anti-clotting medications

		REVA Medical, Inc. Resorbable stent technology

		ReVision Optics, Inc. Developing new technologies, products and procedures aimed at the correction of presbyopia

		ROX Medical, Inc. Device to treat chronic obstructive pulmonary disease

		Sequel Pharmaceuticals, Inc. Cardiovascular drug development

		Sequent Medical, Inc. Dedicated to the development of innovative devices to treat neurovascular disease conditions

		SkinMedica, Inc. Acquires & markets dermatologic products

		Sonexa Therapeutics, Inc. Developing therapeutics for the treatment of Alzheimer's disease

		Syndax Pharmaceuticals, Inc. Development and commercialization of novel cancer therapies

		Tandem Diabetes Care, Inc. Developing novel devices for the treatment of diabetes

		Tandem Diagnostics, Inc. Focused on providing early, non-invasive, and accurate prenatal diagnostic tests for fetal health
Tandem Diagnostics, Inc.

		TargetRx, Inc. Information services for the pharmaceutical industry

		Tobira Therapeutics, Inc. Dedicated to the clinical development of antiviral products

		Tragara Pharmaceuticals, Inc. Development of proprietary drugs for the treatment of cancer and inflammation-related disorders

		VentiRx Pharmaceuticals, Inc. Developing novel drugs for the treatment of cancer, infectious, respiratory and autoimmune diseases.

		Veracyte, Inc. Developing a molecular-based thyroid cancer diagnostic that permits diagnoses without surgery

		Volcano Corporation Detection and treatment of vascular disease

		Zogenix, Inc. Development and commercialization of medicines to treat CNS disorders and pain

		Zyga Technology, Inc. Developing therapies for the treatment of back pain
Zyga Technology, Inc.